Editorial. Comments on a study in this issue by Albert and colleagues on the results of the Pravastatin Inflammation/CRP Evaluation (PRINCE) study. Discussion of the study's results; View that the study is based on good scientific rationale, and adds prospective data to evidence that statins may have a direct effect on an important modulator of atherosclerosis; View that it is unclear how the information from the study may be used clinically.